Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials

Introduction and Objectives: Practicing physicians often hesitate to use statins and/or other lipid-lowering therapies in NAFLD due to concern for hepatotoxicity. The aim of this study is to examine the safety of lipid lowering therapies in NAFLD patients. Materials and Methods: Data from randomized...

Full description

Bibliographic Details
Main Authors: Mohamed Abdallah, Landon Brown, John Provenza, Raseen Tariq, Smitha Gowda, Ashwani K. Singal
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268122000801

Similar Items